Navigation Links
Inhaled Particles Increases the Risk of Lung Cancer

Exposure to certain types of inhaled particles in occupational settings and in the environment has been linked to increases in lung cancer risk. The December// Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM), is a special issue providing updates on particles and cancer.

"A remarkable consistency exists among many types of studies for some particles in terms of their ability to cause cancer," writes Dr. Robert J. McCunney of Massachusetts Institute of Technology in an introductory editorial. "But how does one sort out the disparate results among many studies and make effective decisions in minimizing risk of cancer among people exposed to particles at work or in the environment?" The articles in the special issue—highlights of a recent MIT-sponsored conference—provide new insights into the lung cancer risks associated with particle exposure.

Several studies focus on a particle called carbon black—a fine powder made from incomplete combustion of petroleum that is widely used in the rubber and printing industries. The results of previous studies of workers exposed to carbon black have been unclear: although there was evidence of an increased risk of lung cancer, there was no clear relationship between cancer rates and the level of carbon black exposure.

The new studies provide further evidence of increased risk among workers exposed to carbon black, with lung cancer rates 80 to 120 percent higher than in the general population. Again, however, there is no clear "dose-response" link. The findings are consistent with the recent International Agency for Research on Cancer conclusion that carbon black is "possibly carcinogenic," but that there is not enough scientific evidence to confirm that it was a cancer-causing agent in humans.

The special issue also includes new research on other particles with possible links to cancer, s
'"/>




Page: 1 2

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. The Effectiveness Of Inhaled Corticosteroids Studied
5. Inhaled nitric oxide therapy does not reduce death risk of infants
6. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
7. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
8. Inhaled Insulin To Be Made Available in India
9. Inhaled Insulin Could Rock The Drug Market Soon
10. High Cost Forces NHS To Reject Inhaled Insulin
11. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
Post Your Comments:
(Date:7/25/2008)...o benefit ALS Therapy Alliance to be presented at ..., WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/p...ed a record-breaking $4.4 million in just 21 days,...or ALS research. This is,the seventh year of the a...d more than $15 million for ALS research. This yea...
(Date:7/25/2008)... fluid back-up in esophagus can cause immune syste... News) -- The first evidence linking gastroesophag...overed by Duke University Medical Center researche... was first noted in the 1970s, and since then stud...ent of asthma patients also experience GERD sympto...
(Date:7/25/2008)... New program delivers immediate cost...4-hour telephone access to language interpreters] ...multilingual solutions. , ...E® http://www.lle-inc.com/index.html [(Langu...er of interpretation, translation, and language in...
(Date:7/25/2008)... Whether you are an Olympian, Profes...there are Five Things You Need to Know about Hydra.... Spine and Sports Center , ... America,s premier athletes are heading to Beijing... and sacrifice in the hopes of capturing an Olympi...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...ak at mathematics, reading, and writing better wat...ds, for a research suggests that such symptoms may... than their peers. Authored by Alyssa Bachmann of ...as focused on the parents of 218 second and third ...
...zard mothers dress their children in different col...onditions that the babies will face as adults . R...Cruz, have found that female side-blotched lizards...r patterns in their broods in response to social c...
...esearchers in National Institutes of Health, an in...ementia increases with the number of different dis... findings is the observation that the combination ...rcts (strokes) is the most common mix of pathologi...
... is under immense pressure trying to survive amid ...or help from a woman dying in the emergency room o...d to have been ignored by the in house staff. Lik...too was rejected by the dispatchers, ultimately le...
Other Medicine News:Health News:Students With Sleep Disorder Symptoms Score Badly in Maths 2Health News:Lizard Mothers Dress Their Progeny to Ensure Success in Later Life 2Health News:Lizard Mothers Dress Their Progeny to Ensure Success in Later Life 3Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:Womans Death increases Pressure on LA Hospital to close down 2
(Date:7/23/2008)...CISCO, July 23 /- InCode BioPharmaceu... today announced preclinical test,results demonstr...-1 for,the treatment of the rare chronic blood dis...he complete results will be presented at the XXII,...rland, September 28,2008., The only treatment cu...
(Date:7/22/2008)... efficacy results from a multi-center 293-patient ...oronto Stock Exchange Symbol: CYT, MONTREAL, July...ies,Inc., the global leader in cryotherapy product...at results previously presented from three,Europea...Arctic Front(R),were published earlier today in t...
(Date:7/22/2008)...onstrates Feasibility and Efficacy of Treating Pat...Cancer, SAN FRANCISCO, and YONGIN-SI, South Korea...cisco, CA and Ottawa, Ontario), and its South,Kore... novel findings from,a Phase I clinical trial of i... that the product was well-tolerated and resulted ...
(Date:7/22/2008)...N FRANCISCO, Calif., July 22 /- Hyper... completed patient enrollment,in its Phase 1/2 cli...nd,ammonia scavenging effects of HPN-100 (formally...yrate) in patients with urea cycle disorders,(UCD)...n the fourth quarter,of this year., (Logo: http:...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Speaker judges set for Global Venture Challenge 2483 1STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 1STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 2STALLERGENES 3A Further Profit Growth Acceleration of R 26D Expenditure 3910 3Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 1Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 2Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 3Coalition of Consumer Business Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility 14185 4Killer fungus spells disaster for wheat 2480 1Killer fungus spells disaster for wheat 2480 2Killer fungus spells disaster for wheat 2480 3
...Md., March 29, 2007--For depressed people with bip...ding an antidepressant,medication is no more effec...ults published online on March 28, 2007 in the New... of the,large-scale, multi-site Systematic Treatme...BD), a $26.8 million clinical trial,funded by the ...
...lar Ultrasound Demonstrates Utility in Evaluating ...ous Potential for HDL,Therapy , ,PLEASANTON, CA, M...-- Lipid Sciences, Inc. (NASDAQ: LIPD) Dr. H. Brya...Sciences, Inc., concluded from,the wide range of p...diology (ACC) Meeting in New Orleans that the rati...
Other Medicine Technology:Study Sheds Light on Medication Treatment Options for Bipolar,Disorder 2Study Sheds Light on Medication Treatment Options for Bipolar,Disorder 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
Selecta Trio The pinnacle in the family, combining the Nd:YAG, diode-pumped solid-state (DPSS) 532 Photocoagulator and Q-switched frequency-doubled 532nm laser (SLT) and offering maximum flexibility
Ultimum hemostasis introducers provide outstanding insertion performance, with excellent wire-to-dilator and dilator-to-sheath transitions, high kink resistance and minimal wall thickness. A dual lay
... Haemonetics' latest multi-component platform, whi...the collection of platelets, red cells, plasma, an... possibilities for therapeutic apheresis procedure...llection organizations throughout the world to imp...
The PCS2 system is Haemonetics latest technology for the collection of plasma and flexible protocols allow for the collection of "jumbo" units of platelet-poor plasma, platelet-poor plasma with optio
Medicine Products: